Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel (Primary)
- Indications Cancer
- Focus Pharmacokinetics
Most Recent Events
- 28 Mar 2012 Biomarkers information updated
- 27 Mar 2012 Actual patient number is 33 according to ClinicalTrials.gov.
- 27 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.